Press Releases
June 28, 2016
Sun BioPharma, Inc. Raises $2.0 Million Through Private Placement Transaction
May 23, 2016
Sun BioPharma Completes 1st Patient Cohort & Starts Recruitment of 2nd Cohort Patients in Dose Escalation Phase 1 Study
May 16, 2016
Sun BioPharma Provides Business Update and Reports Financial Results for Q1 2016
March 8, 2016
Sun BioPharma Reports Financial Results for Year Ended 12/31/15
March 3, 2016
Dr. Dalvir S. Gill Appointed to Sun BioPharma Board of Directors
January 6, 2016
Dosing of First Patient in Phase 1 Clinical Study of SBP-101 for Pancreatic Cancer
November 16, 2015
Q3 2015 Earnings Release
Sun BioPharma Files Form 10-Q for Third Quarter 2015 and Provides Business Update
November 9, 2015
Compelling Preclinical Data on Sun BioPharma’s SBP-101 Presented at APA Annual Meeting
October 26, 2015
Sun BioPharma to Present Three Abstracts at the 2015 American Pancreatic Association (APA) Annual Meeting
Presentations to Focus on Pre-Clinical Data for Company’s Lead Development Candidate, SBP-101, for the Treatment of Pancreatic Diseases
October 2, 2015
Scott Kellen Appointed Chief Financial Officer of Sun BioPharma
Healthcare Executive Brings Extensive Public Company Financial Experience to Leadership Team
Events & Presentations